Cargando…

Correlation of Electrophysiological and Fluorescence-Based Measurements of Modulator Efficacy in Nasal Epithelial Cultures Derived from People with Cystic Fibrosis

It has been suggested that in vitro studies of the rescue effect of CFTR modulator drugs in nasal epithelial cultures derived from people with cystic fibrosis have the potential to predict clinical responses to the same drugs. Hence, there is an interest in evaluating different methods for measuring...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gunawardena, Tarini N. A., Bozóky, Zoltán, Bartlett, Claire, Ouyang, Hong, Eckford, Paul D. W., Moraes, Theo J., Ratjen, Felix, Gonska, Tanja, Bear, Christine E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136647/ https://www.ncbi.nlm.nih.gov/pubmed/37190083 http://dx.doi.org/10.3390/cells12081174

Ejemplares similares

A new platform for high-throughput therapy testing on iPSC-derived lung progenitor cells from cystic fibrosis patients
por: Jiang, Jia Xin, et al.
Publicado: (2021)

Preclinical Studies of a Rare CF-Causing Mutation in the Second Nucleotide Binding Domain (c.3700A>G) Show Robust Functional Rescue in Primary Nasal Cultures by Novel CFTR Modulators
por: Laselva, Onofrio, et al.
Publicado: (2020)

Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator
por: Laselva, Onofrio, et al.
Publicado: (2021)

Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis
por: Birimberg-Schwartz, Liron, et al.
Publicado: (2023)

The CFTR Mutation c.3453G > C (D1152H) Confers an Anion Selectivity Defect in Primary Airway Tissue that Can be Rescued by Ivacaftor
por: Laselva, Onofrio, et al.
Publicado: (2020)

Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass
por: Mouzaki, Marialena, et al.
Publicado: (2023)

Perspectives on the translation of in-vitro studies to precision medicine in Cystic Fibrosis
por: Dumas, Marie-Pier, et al.
Publicado: (2021)

Testing gene therapy vectors in human primary nasal epithelial cultures
por: Cao, Huibi, et al.
Publicado: (2015)

Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia
por: Ahmadi, Saumel, et al.
Publicado: (2017)

Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis
por: Perrem, Lucy, et al.
Publicado: (2020)

Letting It All Out: Neutrophils in Early Cystic Fibrosis Airway Inflammation
por: Perrem, Lucy, et al.
Publicado: (2019)

Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics
por: Strug, Lisa J., et al.
Publicado: (2016)

Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis
por: Ooi, Chee Y., et al.
Publicado: (2019)

Orkambi® and amplifier co‐therapy improves function from a rare CFTR mutation in gene‐edited cells and patient tissue
por: Molinski, Steven V, et al.
Publicado: (2017)

L-Ornithine Derived Polyamines in Cystic Fibrosis Airways
por: Grasemann, Hartmut, et al.
Publicado: (2012)

The Equitable Implementation of Cystic Fibrosis Personalized Medicines in Canada
por: Shemie, Genevieve, et al.
Publicado: (2021)

Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis
por: Grasemann, Hartmut, et al.
Publicado: (2006)

Nasal epithelial cell culture fluorescence recovery after photobleaching predicts cystic fibrosis therapeutic response
por: Corcoran, Timothy E., et al.
Publicado: (2022)

Attenuation of Phosphorylation-dependent Activation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Disease-causing Mutations at the Transmission Interface
por: Chin, Stephanie, et al.
Publicado: (2017)

Synthesis and Properties of Molecular Probes for the Rescue Site on Mutant Cystic Fibrosis Transmembrane Conductance Regulator
por: Alkhouri, Bashar, et al.
Publicado: (2011)

Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients
por: Griese, Matthias, et al.
Publicado: (2005)

Human Nasal Epithelial Organoids for Therapeutic Development in Cystic Fibrosis
por: Liu, Zhongyu, et al.
Publicado: (2020)

Surfactant Protein A in Cystic Fibrosis: Supratrimeric Structure and Pulmonary Outcome
por: Griese, Matthias, et al.
Publicado: (2012)

Modulator Therapy in Cystic Fibrosis Patients with cis Variants in F508del Complex Allele: A Short-Term Observational Case Series
por: Terlizzi, Vito, et al.
Publicado: (2022)

Proteomic Analysis of Nasal Epithelial Cells from Cystic Fibrosis Patients
por: Jeanson, Ludovic, et al.
Publicado: (2014)

Nasal Epithelial Cell-Based Models for Individualized Study in Cystic Fibrosis
por: Keegan, Duncan E., et al.
Publicado: (2021)

Novel Outcome Measures for Clinical Trials in Cystic Fibrosis
por: Tiddens, Harm AWM, et al.
Publicado: (2015)

Nasal endoscopic evaluation of children and adolescents with cystic fibrosis
por: Paiva Franco, Letícia, et al.
Publicado: (2015)

A Developmental Role of the Cystic Fibrosis Transmembrane Conductance Regulator in Cystic Fibrosis Lung Disease Pathogenesis
por: Huang, Elena N., et al.
Publicado: (2021)

The Sweat Metabolome of Screen-Positive Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport
por: Macedo, Adriana N., et al.
Publicado: (2017)

β‐adrenergic sweat test in children with inconclusive cystic fibrosis diagnosis: Do we need new reference ranges?
por: Zampoli, Marco, et al.
Publicado: (2022)

Cytokine profile in subjects with Cystic Fibrosis and nasal polyposis compared to patients with no nasal disorders
por: Nunes, Flávio Barbosa, et al.
Publicado: (2015)

A transistor model for the cystic fibrosis transmembrane conductance regulator
por: Hunt, William D., et al.
Publicado: (2023)

Incidence and evolution of nasal polyps in children and adolescents with cystic fibrosis
por: Weber, Silke Anna Thereza, et al.
Publicado: (2015)

Testing Two Different Doses of Tiotropium Respimat® in Cystic Fibrosis: Phase 2 Randomized Trial Results
por: Bradley, Judy M., et al.
Publicado: (2014)

Buserelin alleviates chloride transport defect in human cystic fibrosis nasal epithelial cells
por: Calvez, Marie-Laure, et al.
Publicado: (2017)

Nasal Potential Difference in Cystic Fibrosis considering Severe CFTR Mutations
por: Ng, Ronny Tah Yen, et al.
Publicado: (2015)

Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment
por: Kang, Suzie Hyeona, et al.
Publicado: (2015)

Nasal Resistome Development in Infants With Cystic Fibrosis in the First Year of Life
por: Allemann, Aurélie, et al.
Publicado: (2019)

Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells
por: Scudieri, Paolo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_id501hh15tgj8mt7754ga8cbh0